|
π
|
Identification of the breast cancer susceptibility gene BRCA2
43 auth.
R. Wooster,
G. Bignell,
J. Lancaster,
S. Swift,
S. Seal,
J. Mangion,
N. Collins,
S. Gregory,
C. Gumbs,
G. Micklem,
R. Barfoot,
R. Hamoudi,
Sandeep Patel,
Catherine Rices,
P. Biggs,
...
Yasmin Hashim,
Amanda Smith,
F. Connor,
A. Arason,
J. Gudmundsson,
David Flcenec,
D. Kelsell,
D. Ford,
P. Tonin,
P. Tonin,
D. Bishop,
N. Spurr,
B. Ponder,
R. Eeles,
J. Peto,
P. Devilee,
C. Cornelisse,
H. Lynch,
S. Narod,
S. Narod,
G. Lenoir,
V. Egilsson,
Rosa Bjork Barkadottir,
D. Easton,
D. Bentley,
P. Futreal,
A. Ashworth,
M. Stratton
|
11 |
1995 |
11
π
|
|
π’
|
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
14 auth.
L. Mulligan,
J. Kwok,
C. Healey,
M. Elsdon,
C. Eng,
E. Gardner,
D. Love,
S. Mole,
Julie K. Moore,
L. Papi,
...
M. Ponder,
H. Telenius,
A. Tunnacliffe,
B. Ponder
|
10 |
1993 |
10
π’
|
|
π
|
Identification of the breast cancer susceptibility gene BRCA2
41 auth.
R. Wooster,
G. Bignell,
J. Lancaster,
S. Swift,
S. Seal,
J. Mangion,
N. Collins,
S. Gregory,
C. Gumbs,
Gos Michlem,
R. Barfoot,
R. Hamoudi,
Sandeep Patel,
C. Rice,
P. Biggs,
...
Yasmin Hashim,
Amanda Smith,
F. Connor,
A. Arason,
J. Gudmundsson,
D. Ficenec,
D. Kelsell,
D. Ford,
P. Tonin,
D. Bishop,
N. Spurr,
B. Ponder,
R. Eeles,
J. Peto,
P. Devilee,
C. Cornelisse,
H. Lynch,
S. Narod,
G. Lenoir,
V. Egilsson,
Rosa Bjork Barkadottir,
D. Easton,
D. Bentley,
P. Futreal,
A. Ashworth,
M. Stratton
|
10 |
1996 |
10
π
|
|
π
|
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
33 auth.
C. Eng,
C. Eng,
D. Clayton,
I. Schuffenecker,
G. Lenoir,
G. Cote,
R. Gagel,
H. C. P. Amstel,
C. Lips,
I. Nishisho,
S. Takai,
D. Marsh,
D. Marsh,
Bruce G. Robinson,
K. FrankβRaue,
...
F. Raue,
Feiyu Xue,
W. Noll,
C. Romei,
F. Pacini,
M. Fink,
B. Niederle,
J. Zedenius,
M. NordenskjΓΆld,
P. Komminoth,
G. Hendy,
H. Gharib,
S. Thibodeau,
A. Lacroix,
A. Frilling,
B. Ponder,
B. Ponder,
L. Mulligan
|
10 |
1996 |
10
π
|
|
π
|
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
14 auth.
Songyang Zhou,
K. Carraway,
M. Eck,
S. Harrison,
R. Feldman,
M. Mohammadi,
J. Schlessinger,
S. Hubbard,
Darrin P. Smith,
C. Eng,
...
M. J. Lorenzo,
B. Ponder,
B. Mayer,
L. Cantley
|
9 |
1995 |
9
π
|
|
π’
|
Polygenic susceptibility to breast cancer and implications for prevention
P. Pharoah,
A. Antoniou,
M. Bobrow,
R. Zimmern,
D. Easton,
B. Ponder
|
9 |
2002 |
9
π’
|
|
π
|
GDNF signalling through the Ret receptor tyrosine kinase
12 auth.
P. Durbec,
Camelia V. Marcos-Gutierrez,
Carol Kilkenny,
Maria Grigoriou,
Kirmo Wartiowaara,
P. Suvanto,
...
Darrin P. Smith,
B. Ponder,
F. Costantini,
M. Saarma,
H. Sariola,
V. Pachnis
|
9 |
1996 |
9
π
|
|
π
|
Mutations of the RET proto-oncogene in Hirschsprung's disease
10 auth.
P. Edery,
S. Lyonnet,
L. Mulligan,
A. Pelet,
E. Dow,
L. Abel,
...
S. Holder,
C. Nihoul-FeΜkeΜteΜ,
B. Ponder,
A. Munnich
|
9 |
1994 |
9
π
|
|
π
|
Von HippelΒLindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
31 auth.
B. Seizinger,
G. Rouleau,
L. Ozelius,
A. Lane,
G. Farmer,
J. Lamiell,
J. Haines,
J. Yuen,
D. Collins,
D. Majoor-Krakauer,
T. Bonner,
C. Mathew,
A. Rubenstein,
J. Halperin,
A. McConkie-Rosell,
...
J. Green,
J. Trofatter,
B. Ponder,
L. Eierman,
M. Bowmer,
R. Schimke,
B. Oostra,
N. Aronin,
David I. Smith,
H. Drabkin,
M. Waziri,
W. Hobbs,
R. Martuza,
P. Conneally,
Y. Hsia,
J. Gusella
|
9 |
1988 |
9
π
|
|
π’
|
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
13 auth.
L. Mulligan,
C. Eng,
C. Healey,
D. Clayton,
J. Kwok,
E. Gardner,
M. Ponder,
A. Frilling,
C. Jackson,
H. Lehnert,
...
H. Neumann,
S. Thibodeau,
B. Ponder
|
9 |
1994 |
9
π’
|
|
π’
|
The genetics and genomics of cancer
A. Balmain,
J. Gray,
B. Ponder
|
9 |
2003 |
9
π’
|
|
π
|
Mutations truncating the EP300 acetylase in human cancers
14 auth.
S. Gayther,
Sarah J. Batley,
Lori Linger,
Andrew J. Bannister,
K. Thorpe,
S. Chin,
Y. Daigo,
P. Russell,
Annie Wilson,
H. Sowter,
...
J. Delhanty,
B. Ponder,
T. Kouzarides,
C. Caldas
|
9 |
2000 |
9
π
|
|
π
|
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
13 auth.
S. Narod,
H. Risch,
R. Moslehi,
A. DΓΈrum,
S. Neuhausen,
H. Olsson,
D. Provencher,
P. Radice,
G. Evans,
S. Bishop,
...
J. Brunet,
B. Ponder,
J. Klijn
|
9 |
1998 |
9
π
|
